BioCentury | Jul 5, 2010
Company News

ProStrakan, Uluru, Crawford Pharmaceuticals deal

...ProStrakan's Strakan International Ltd. subsidiary and partner Uluru will divest their interest in acne drug Zindaclin...
BioCentury | May 31, 2010
Finance

Performance Counts

BioCentury's eighth annual review of the financing needs for European biotech shows a record number of biopharma companies have reached the clinic and beyond. While in total these private and public biotechs also have registered...
BioCentury | Jan 1, 2007
Strategy

Double-dipping on ProSkelia

...by the 2004 merger of musculoskeletal company ProSkelia S.A. and bone and skin diseases company Strakan Group Ltd....
...brought three compounds in Phase II testing and three small molecule discovery research programs, while Strakan...
BioCentury | Dec 4, 2006
Company News

Cellegy, ProStrakan deal

...PSK's Strakan International Ltd. unit completed its previously announced acquisition of CLGY's Tostrex ( Tostran...
BioCentury | Oct 2, 2006
Company News

ProStrakan, Novartis deal

...to small molecules against the target. The target came from ProSkelia S.A., which merged with Strakan Group Ltd....
BioCentury | Nov 21, 2005
Finance

Ebb & Flow

...Therapeutic peptide developer Jerini (FSE:JI4) raised E49.6 million ($58.2 million) in its October IPO, while Pro-Strakan...
BioCentury | Oct 31, 2005
Finance

Liquidity preference

...the merger of French musculoskeletal play Proskelia S.A. and the U.K. musculoskeletal and dermatology company Strakan Group Ltd....
BioCentury | May 9, 2005
Strategy

Acquiring markets

...When French drug discovery play ProSkelia SA and U.K. specialty pharma Strakan Group Ltd. merged last year to...
BioCentury | Apr 18, 2005
Finance

Ebb & Flow

...Dec. 6, 2004). The company, formed by the merger of France's ProSkelia and the U.K.'s Strakan...
BioCentury | Dec 6, 2004
Finance

Ebb & Flow

...infection (see B6). ProStrakan will merge Elfar with another Spanish company, Devon Farmaceutica, to form Strakan...
Items per page:
1 - 10 of 59
BioCentury | Jul 5, 2010
Company News

ProStrakan, Uluru, Crawford Pharmaceuticals deal

...ProStrakan's Strakan International Ltd. subsidiary and partner Uluru will divest their interest in acne drug Zindaclin...
BioCentury | May 31, 2010
Finance

Performance Counts

BioCentury's eighth annual review of the financing needs for European biotech shows a record number of biopharma companies have reached the clinic and beyond. While in total these private and public biotechs also have registered...
BioCentury | Jan 1, 2007
Strategy

Double-dipping on ProSkelia

...by the 2004 merger of musculoskeletal company ProSkelia S.A. and bone and skin diseases company Strakan Group Ltd....
...brought three compounds in Phase II testing and three small molecule discovery research programs, while Strakan...
BioCentury | Dec 4, 2006
Company News

Cellegy, ProStrakan deal

...PSK's Strakan International Ltd. unit completed its previously announced acquisition of CLGY's Tostrex ( Tostran...
BioCentury | Oct 2, 2006
Company News

ProStrakan, Novartis deal

...to small molecules against the target. The target came from ProSkelia S.A., which merged with Strakan Group Ltd....
BioCentury | Nov 21, 2005
Finance

Ebb & Flow

...Therapeutic peptide developer Jerini (FSE:JI4) raised E49.6 million ($58.2 million) in its October IPO, while Pro-Strakan...
BioCentury | Oct 31, 2005
Finance

Liquidity preference

...the merger of French musculoskeletal play Proskelia S.A. and the U.K. musculoskeletal and dermatology company Strakan Group Ltd....
BioCentury | May 9, 2005
Strategy

Acquiring markets

...When French drug discovery play ProSkelia SA and U.K. specialty pharma Strakan Group Ltd. merged last year to...
BioCentury | Apr 18, 2005
Finance

Ebb & Flow

...Dec. 6, 2004). The company, formed by the merger of France's ProSkelia and the U.K.'s Strakan...
BioCentury | Dec 6, 2004
Finance

Ebb & Flow

...infection (see B6). ProStrakan will merge Elfar with another Spanish company, Devon Farmaceutica, to form Strakan...
Items per page:
1 - 10 of 59